Premium
PRELIMINARY RESULTS OF A PHASE 1B STUDY OF TIRABRUTINIB (GS‐4059/ONO‐4059) IN COMBINATION WITH ENTOSPLETINIB IN PATIENTS WITH B‐CELL MALIGNANCIES
Author(s) -
Morschhauser F.,
Danilov A.V.,
Hodson D.J.,
Salles G.A.,
Starodub A.,
Mitra S.,
Yang Y.,
Walter H.,
Fegan C.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2438_136
Subject(s) - medicine , neutropenia , tolerability , rash , gastroenterology , adverse effect , progressive disease , anemia , nausea , disease , toxicity
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom